Olopatadine HCL 0.1% Ophthalmic Solution

Award NoticeAwarded

This federal contract opportunity has been awarded to on February 15, 2023.

Award Information

This solicitation resulted in an award to for approximately $17,621,453 on February 15, 2023. Similar contracts are typically issued by DEPT OF DEFENSE under 325412 (Pharmaceutical Preparation Manufacturing).

Award Number
SPE2D223D0007
Award Amount
$17,621,453
Award Date
February 15, 2023

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Pharmaceutical Preparation Manufacturing

Contract Details

Notice ID
SPE2D222R0117
Opportunity Type
Award Notice
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Thursday, September 24, 2026
Response Deadline
Not specified
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

Modification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience. Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective Febr

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for pharmaceutical preparation manufacturing in PHILADELPHIA, PA.